Full Text View
Tabular View
Study Results
Related Studies
Artemisinin to Reduce The Symptoms of Schizophrenia
This study has been completed.
Study NCT00753506   Information provided by Sheppard Pratt Health System

First Received on September 15, 2008.   Last Updated on February 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Additional conditions recognized in this trial
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Artemisinin
Identical looking placebo capsule
Additional drug interventions recognized in this trial
Artemisinine
Artemisinins
More general drug interventions related to this trial
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sheppard Pratt Health System
Stanley Medical Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services